December 17, 2010 | Filed under: Health,News | Posted by:
AstraZeneca’s new blood thinner Brilinta worked better than Plavix in a head-to-head clinical trial — but not in U.S. and Canadian patients. The FDA won’t approve the drug without a new analysis of the study.
Posted by
on December 17, 2010. Filed under Health, News.
You can follow any responses to this entry through the RSS 2.0.
You can leave a response or trackback to this entry
Posted by
on December 17, 2010. Filed under